Skip to main content

Part of the book series: Current Clinical Practice ((CCP))

  • 1028 Accesses

Abstract

It is estimated that more than 40 million women will experience menopause during the next 20 years. For most women, approximately one-third of their life will occur in the postmenopausal period (1). Menopause represents a distinct event or stage in the life of a woman that is normal and may have a positive and liberating effect. For a health care provider and for the woman herself, menopause represents an opportunity to assess concerns and implement important disease prevention and health maintenance interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Paoletti R, Wenger NK. Review of the international position paper on women’s health and menopause: a comprehensive approach. Circulation 2003;107(9):1336–1339.

    Article  PubMed  Google Scholar 

  2. Stenchever M, Droegemuellor W, Herbst A, et al. Comprehensive Gynecology. Mosby, St. Louis, 2001.

    Google Scholar 

  3. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88(6):2404–2411.

    Article  CAS  PubMed  Google Scholar 

  4. Nelson HD, Haney E, Humphrey L, et al. Management of Menopause-Related Symptoms. Summary, Evidence Report/Technology Assessment No. 120 (prepared by the Oregon Evidence-based practice center, under contract No. 290-02-0024) AHRQ Publication no. 05-E016-1. Agency for Healthcare Research and Quality, Rockville, MD, March 2005.

    Google Scholar 

  5. Soares CN, Joffe H, Steiner M. Menopause and mood. Clin Obstet Gynecol 2004;47(3):576–591.

    Article  PubMed  Google Scholar 

  6. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective populationbased study of menopausal symptoms. Obstet Gynecol 2000;96(3):351–358.

    Article  CAS  PubMed  Google Scholar 

  7. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women’s Health Study: toward a more precise definition. Menopause: The Journal of the North American Menopause Society 2000;7(5):334–349.

    CAS  Google Scholar 

  8. Santoro N. The menopause transition: an update. Hum Reprod Update 2002;8(2):155–160.

    Article  PubMed  Google Scholar 

  9. Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM. Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 2004;89(6):2763–2769.

    Article  CAS  PubMed  Google Scholar 

  10. Burger HG, Dudley EC, Hopper JL, et al. Prospectively measured levels of serum folliclestimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999;84(11):4025–4030.

    Article  CAS  PubMed  Google Scholar 

  11. Dudley EC, Hopper JL, Taffe J, Guthrie JR, Burger HG, Dennerstein L. Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric 1998; 1(1):18–25.

    Article  CAS  PubMed  Google Scholar 

  12. Taffe JR, Dennerstein L. Menstrual patterns leading to the final menstrual period. Menopause 2002;9(1):32–40.

    Article  PubMed  Google Scholar 

  13. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000;152(5):463–473.

    Article  CAS  PubMed  Google Scholar 

  14. Santoro N, Chervenak JL. The menopause transition. Endocrinol Metabol Clin North Am 2004;33(4):627–636.

    Article  Google Scholar 

  15. Freeman EW, Sammel MD, Rinaudo PJ, Sheng L. Premenstrual syndrome as a predicator of menopausal symptoms. Obstet Gynecol 2004; 103(5 Pt 1):960–966.

    CAS  PubMed  Google Scholar 

  16. American College of Obstetricians and Gynecologists. Vasomotor symptoms. Obstet Gynecol 2004;104(4 Suppl):106S–117S.

    Google Scholar 

  17. Kaunitz AM. Gynecologic problems of the perimenopause: evaluation and treatment. Obstet Gynecol Clin North Am 2002;29(3):455–473.

    Article  PubMed  Google Scholar 

  18. Mohyi D, Tabassi K, Simon J. Differential diagnosis of hot flashes. Maturitas 1997;27:203–214.

    Article  CAS  PubMed  Google Scholar 

  19. American College of Obstetricians and Gynecologists. Genitourinary tract changes. Obstet Gynecol 2004;104(4 Suppl):56S–61S.

    Google Scholar 

  20. Ouhilal S, Harrison E, Santoro N. Perimenopausal Bleeding in Menstrual Disorders: A Practical Guide. ACP Press, Philadelphia. In press.

    Google Scholar 

  21. Leclair C, Ehrenthal D, Adams Hillard P. Amenorrhea and Oligomenorrhea, in Menstrual Disorders, A Practical Guide. ACP Press, Philadelphia, PA. In press.

    Google Scholar 

  22. Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM. Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metabol 2004;89:2763.

    Article  CAS  Google Scholar 

  23. Speroff L. Clinical Gynecologic Endocrinology and Infertility, 6th ed. Lipincott Williams and Wilkins, 1999, p. 662.

    Google Scholar 

  24. Edmunds E, Lip GY. Cardiovascular risk in women: the cardiologist’s perspective. Quart J Med 2000;93(3):135–145.

    CAS  Google Scholar 

  25. American Diabetes Association. Screening for Type 2 Diabetes. Diabetes Care 2004; 27(Suppl 1):S11–S14.

    Google Scholar 

  26. United States Preventive Services Task Force, Screening for Diabetes, Adult Type 2. www.ahrq.gov/clinic/uspstfix.htm.

    Google Scholar 

  27. Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137:529–541.

    PubMed  Google Scholar 

  28. Smith RA, Saslow D, Sawyer KA, et al. and the American Cancer Society High-Risk Work Group; American Cancer Society Screening Older Women Work Group; American Cancer Society Mammography Work Group; American Cancer Society Physical Examination Work Group; American Cancer Society New Technologies Work Group; American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53(3):141–169.

    Article  PubMed  Google Scholar 

  29. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 42, April 2003. Breast cancer screening. Obstet Gynecol 2003;101(4):821–831.

    Article  Google Scholar 

  30. Waxman AG. Guidelines for cervical cancer screening: history and scientific rationale. Clin Obstet Gynecol 2005;48(1):77–97.

    Article  PubMed  Google Scholar 

  31. Walsh JME, Terdimamn JP. Colorectal cancer screening clinical applications. JAMA 2003; 289(10):1297–1302.

    Article  PubMed  Google Scholar 

  32. Speroff L, Massaferri EL. Hormone replacement therapy: clarifying the picture. Hosp Pract 2001;36(5):37–46.

    Article  CAS  Google Scholar 

  33. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. NEJM 1999;340:1801–1811.

    Article  CAS  PubMed  Google Scholar 

  34. Hully S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/ Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605–652.

    Article  Google Scholar 

  35. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA 2002;288(1):49–57.

    Article  PubMed  Google Scholar 

  36. Writing group for the women’s health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288(3):321–333.

    Article  Google Scholar 

  37. The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative Randomized Controlled Trial. JAMA 2004;291(14):1701–1712.

    Article  Google Scholar 

  38. Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. NEJM 2003;348(7):645–650.

    Article  PubMed  Google Scholar 

  39. Schairer C, Lubin J, Troisi R, et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485–491.

    Article  CAS  PubMed  Google Scholar 

  40. Langer RD. Postmenopausal hormone therapy: what’s appropriate today. CME Bulletin. American Academy of Family Physicians 2005;4(1):1–12.

    Google Scholar 

  41. Gapstur SM, Morrow M, Sellers TA. Hormone Replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women’s Health Study. JAMA 1999;281:2091–2097.

    Article  CAS  PubMed  Google Scholar 

  42. Grady D, Wngern NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the heart and estrogen/progestin replacement study. Ann Intern Med 2000; 132:689–696.

    CAS  PubMed  Google Scholar 

  43. Viscoli CM, Brass LLM, Kernn WN, Sarrel PM, Suissa S, Horwitz RI. Estrogen therapy and risk of cognitive decline; results from the women’s estrogen for stroke trial (WEST). Am J Obstet Gynecol 2005;192(2):387–393.

    Article  CAS  PubMed  Google Scholar 

  44. Grodstein F, Martinez ME, Platz EA, et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 1998;128(9):705–712.

    CAS  PubMed  Google Scholar 

  45. Hayes J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. NEJM 2003;348(19):L1839–L1854.

    Article  Google Scholar 

  46. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the women’s health initiative memory study; a randomized controlled trial. JAMA 2003;289(20):2663–2672.

    Article  CAS  PubMed  Google Scholar 

  47. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women’s health initiative memory study; a randomized controlled trial. JAMA 2003;289(20):2651–2662.

    Article  CAS  PubMed  Google Scholar 

  48. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA 2002;288(17):2123–2129.

    Article  CAS  PubMed  Google Scholar 

  49. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289(21):2827–2834.

    Article  CAS  PubMed  Google Scholar 

  50. Nevin JE, Pharr ME. Preventive care for the menopausal woman. Prim Care Clin Office Pract 2002;29:583–597.

    Article  Google Scholar 

  51. Newton KM, Buist DS, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 2002; 100(1):18–25.

    Article  PubMed  Google Scholar 

  52. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002; 137(10):805–813.

    PubMed  Google Scholar 

  53. Liske E, Hanggi W. Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahifs VW. Physiological investigation of a unique extract of black cohosh (cimicifugae racemosae rhizoma): a 6 month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 2002; 11(2):163–174.

    Article  CAS  PubMed  Google Scholar 

  54. Lupu R, Mehmi I, Atlas E, et al. Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. Int J Oncol 2003;23(5):1407–1412.

    CAS  PubMed  Google Scholar 

  55. Pockaj BA, Loprinzi CL, Sloan JA, et al. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 2004;22(4):515–521.

    Article  PubMed  Google Scholar 

  56. Huntley A, Ernst E. A systematic review of the safety of black cohost. Menopause 2003: 10(1):58–64.

    PubMed  Google Scholar 

  57. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19(10):2739–2745.

    CAS  PubMed  Google Scholar 

  58. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004;104(4):824–836.

    CAS  PubMed  Google Scholar 

  59. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, DeAloysio D. The effect of dietary soy supplmentation on hot flushes. Obstet Gynecol 1998;91(1):6–11.

    Article  CAS  PubMed  Google Scholar 

  60. Han KK, Soares JM Jr., Haidar MA, DeLima GR, Garacat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002;99(3):389–394.

    Article  CAS  PubMed  Google Scholar 

  61. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333(5):276–282.

    Article  CAS  PubMed  Google Scholar 

  62. Roughead ZK, Hunt JR, Johnson LK, Badger TM, Lykken GI. Controlled substitution of soy protein for meat protein; effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women. J Clin Endocrinol Metab 2005;90(1):181–189.

    Article  CAS  PubMed  Google Scholar 

  63. Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density and plasma lipids in postmenopausal women; a randomized controlled trial. JAMA 2004;292(1):65–74.

    Article  CAS  PubMed  Google Scholar 

  64. Irvin JH, Domar AD, Clark C, et al. The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynaecol 1996; 17(4):202–207.

    Article  CAS  PubMed  Google Scholar 

  65. Casper F, Petri E. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and placebo-controlled multicenter study. Vaginal Ring Study Group. Int Urogynecol J Pelvic Floor Dysfunct 1999;10(3):171–176.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Nevin, J.E., Ehrenthal, D. (2008). Menopause. In: Clouse, A.L., Sherif, K. (eds) Women’s Health in Clinical Practice. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-469-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-469-8_3

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-631-3

  • Online ISBN: 978-1-59745-469-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics